# Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C

> **NCT00433108** · PHASE2 · COMPLETED · sponsor: **Antipodean Pharmaceuticals, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Mitoquinone mesylate (MitoQ)

## Key facts

- **NCT ID:** NCT00433108
- **Lead sponsor:** Antipodean Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** —
- **Final completion:** 2007-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00433108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00433108, "Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00433108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*